Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Umehara

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biological & Pharmaceutical Bulletin|May 30, 2002
Inhibition of human drug metabolizing cytochrome P450 by buprenorphineKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
Cardiovascular Drugs and Therapy|November 29, 2011
Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptanMasayuki Furukawa, Ken Umehara, Eiji Kashiyama
Biological & Pharmaceutical Bulletin|July 17, 2004
Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomesKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 28, 2015
Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodiesYoshiya Yamamura, Noriyuki Koyama, Ken Umehara
Biological & Pharmaceutical Bulletin|August 21, 2002
Effect of probucol on cytochrome P450 activities in human liver microsomesKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
The Journal of Toxicological Sciences|January 4, 2023
Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acidsToshihisa Koga, Kenji Takeuchi, Ken Umehara
Experimental and Therapeutic Medicine|November 28, 2012
Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in ratsKenji Takeuchi, Masakazu Shibata, Eiji Kashiyama, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 13, 2014
Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic studyMasayuki Furukawa, Yuko Yamasaki, Yukihiro Hirao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 18, 2019
Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline-Containing Thiol Adducts Formed via Cysteine or Glutathione ConjugationKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Biochemical Pharmacology|September 3, 2018
Identification of a novel metabolite of vildagliptin in humans: Cysteine targets the nitrile moiety to form a thiazoline ringKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biological & Pharmaceutical Bulletin|May 30, 2002
Inhibition of human drug metabolizing cytochrome P450 by buprenorphineKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
Cardiovascular Drugs and Therapy|November 29, 2011
Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptanMasayuki Furukawa, Ken Umehara, Eiji Kashiyama
Biological & Pharmaceutical Bulletin|July 17, 2004
Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomesKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 28, 2015
Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodiesYoshiya Yamamura, Noriyuki Koyama, Ken Umehara
Biological & Pharmaceutical Bulletin|August 21, 2002
Effect of probucol on cytochrome P450 activities in human liver microsomesKen Umehara, Yoshihiko Shimokawa, Gohachiro Miyamoto
The Journal of Toxicological Sciences|January 4, 2023
Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acidsToshihisa Koga, Kenji Takeuchi, Ken Umehara
Experimental and Therapeutic Medicine|November 28, 2012
Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in ratsKenji Takeuchi, Masakazu Shibata, Eiji Kashiyama, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 13, 2014
Enantioselective analysis of tolvaptan in rat and dog sera by high-performance liquid chromatography and application to pharmacokinetic studyMasayuki Furukawa, Yuko Yamasaki, Yukihiro Hirao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 18, 2019
Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline-Containing Thiol Adducts Formed via Cysteine or Glutathione ConjugationKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Biochemical Pharmacology|September 3, 2018
Identification of a novel metabolite of vildagliptin in humans: Cysteine targets the nitrile moiety to form a thiazoline ringKatsuhiko Mizuno, Kenji Takeuchi, Ken Umehara, et al.
Pageof 4